abstract |
Dry powder pharmaceutical compositions containing porous carrier particles and active agent particles for pulmonary delivery. The porous carrier particles and active agent particles form an ordered mixture of inhalable agglomerates for the treatment of lung diseases. Active agent particles may contain 1, 2, 3 or more active ingredients. A spray drying process for preparing respirable agglomerates is also described. |